Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jan 26;58(2):188.
doi: 10.3390/medicina58020188.

MDR Tuberculosis Treatment

Juan Espinosa-Pereiro  1   2 , Adrian Sánchez-Montalvá  1   2 , Maria Luisa Aznar  1   2 , Maria Espiau  3
Affiliations
Review

MDR Tuberculosis Treatment

Juan Espinosa-Pereiro et al. Medicina (Kaunas). .

Abstract

Multidrug-resistant (MDR) tuberculosis (TB), resistant to isoniazid and rifampicin, continues to be one of the most important threats to controlling the TB epidemic. Over the last few years, there have been promising pharmacological advances in the paradigm of MDR TB treatment: new and repurposed drugs have shown excellent bactericidal and sterilizing activity against Mycobacterium tuberculosis and several all-oral short regimens to treat MDR TB have shown promising results. The purpose of this comprehensive review is to summarize the most important drugs currently used to treat MDR TB, the recommended regimens to treat MDR TB, and we also summarize new insights into the treatment of patients with MDR TB.

Keywords: MDR; treatment; tuberculosis.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflict of interest to declare.

References

    1. World Health Organization . Global Tuberculosis Report 2021. World Health Organization; Geneva, Switzerland: 2021.
    1. World Health Organization Implementing the End TB Strategy. Antimicrob. Agents Chemother. 2014;58:7250–7257. - PubMed
    1. World Health Organization . WHO Treatment of Tuberculosis Guidelines. 4th ed. World Health Organization; Geneva, Switzerland: 2010.
    1. Falzon D., Schünemann H.J., Harausz E., González-Angulo L., Lienhardt C., Jaramillo E., Weyer K. World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update. Eur. Respir. J. 2017;49:1602308. doi: 10.1183/13993003.02308-2016. - DOI - PMC - PubMed
    1. van Deun A., Maug A.K.J., Salim M.A.H., Das P.K., Sarker M.R., Daru P., Rieder H.L. Short, highly effective, and inexpensive standardized treatment of multidrug-resistant tuberculosis. Am. J. Respir. Crit. Care Med. 2010;182:684–692. doi: 10.1164/rccm.201001-0077OC. - DOI - PubMed

MeSH terms

LinkOut - more resources